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ABSTRACT: Tendon injuries occur frequently in physically active individuals, but the clinical outcomes for these injuries can be poor.
In many injured tissues the repair process is orchestrated by two types of cells, macrophages and fibroblasts. Macrophages, which have
both pro-inflammatory (M1) and anti-inflammatory (M2) phenotypes, can directly participate in tissue remodeling and direct the
response of other cells through the secretion of cytokines and growth factors. In many organ systems, epithelial cells can trans-
differentiate into fibroblasts, which can then regenerate damaged ECM. This process is triggered via activation of epithelial-to-
mesenchymal transition (EMT) signaling programs. Most tendons are surrounded by sheets of epithelial cells, and these tissue layers
could provide a source of fibroblasts to repair injured tendons. To gain greater insight into the biology of tendon repair, we performed a
tenotomy and repair in Achilles tendons of adult rats and determined changes in macrophage phenotype, and ECM- and EMT-related
genes over a 4-week time course. The results from this study suggest that changes in macrophage phenotype and activation of EMT-
related programs likely contribute to the degradation and subsequent repair of injured tendon tissue.  2014 Orthopaedic Research
Society. Published by Wiley Periodicals, Inc. J Orthop Res 32:944–951, 2014.
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Tendon is a dynamic tissue that promotes efficient
force transmission and drives locomotion by connect-
ing muscle to bone. Injuries and diseases of tendons
produce significant morbidity in patients, including
debilitating pain and a decrease in functional capaci-
ty.1 While the etiology of tendon injury remains
unclear, the accumulation of degenerative changes in
the tendon extracellular matrix (ECM) over time
predisposes the patient to spontaneous tendon rup-
ture.1,2 Repetitive microtrauma is thought to over-
whelm the ability of tendon fibroblasts to repair the
injured ECM network, and this likely leads to varie-
gated cellularity, increased vascular elements, and
collagen fibril disorganization.1,3 Indeed, degenerative
tendinopathy is the most common histological finding
at the site of tendon rupture, and reversal of this
process can be challenging because tendons are partic-
ularly slow to heal.4 Accordingly, the management of
tendon injuries is an exigent task for clinicians, and in
many cases, patients remain symptomatic despite
optimal therapy.2 In order to improve the treatment of
tendon injuries, a greater understanding of the cellu-
lar and molecular factors that drive tendon healing is
required.
In many injured tissues, the repair process proceeds
through three overlapping stages described as the
inflammatory, proliferative, and remodeling phases.2,5
Although, numerous cell types play important roles in
tendon healing, the repair of injured tendon tissue is
thought to be orchestrated by two types of cells,
macrophages and fibroblasts.1 Following the initial
recruitment of neutrophils to the site of injury, an
accumulation of macrophages is observed in the ten-
don ECM within the first 24h.6 Macrophages partici-
pate in the phagocytic removal of necrotic debris, but
eventually shift their function to promote fibroblast
proliferation and guide ECM remodeling through the
release of chemotactic and growth factors.2,5,7,8 Macro-
phages have two general phenotypes––classically acti-
vated pro-inflammatory macrophages (M1) that
promote ECM breakdown, inflammation, and apopto-
sis; and alternatively activated anti-inflammatory
macrophages (M2) that coordinate ECM deposition
and tissue repair.9,10 Previous work in damaged skele-
tal muscle has demonstrated that suppression of either
M1 or M2 macrophage function severely impairs tissue
regeneration, indicating the important balance be-
tween inflammation and regeneration for proper tissue
repair.11
Fibroblasts are the predominant cell type in tendons
and are responsible for the development, maintenance,
repair, and modification of the tendon ECM.12 In
response to tissue injury, fibroblasts synthesize ECM
proteins, including collagens, proteoglycans, and glyco-
proteins.12 Fibroblasts also release matrix metallopro-
teinases (MMPs), a family of zinc-dependent enzymes
that selectively degrade various components of the
ECM network, and their endogenous inhibitors, tissue
inhibitors of metalloproteinases (TIMPs).3 The levels of
MMPs and TIMPs fluctuate throughout the repair
process, which culminates in the eventual replacement
of the damaged tendon ECM with newly synthesized
collagen and non-collagenous proteins.1,2,12 Previous
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work has demonstrated that the epitenon, a loose
epithelial-like tissue layer that surrounds the tendon,
may serve as a source of fibroblasts contributing to
tendon growth and repair.13,14 In other organ systems,
reactivation of one or more members of the Snail
family of transcription factors promotes the trans-
differentiation of epithelial cells to a mesenchymal cell
lineage through a process known as epithelial-to-
mesenchymal transition (EMT).15–17 Once in the mes-
enchymal lineage, the cells adopt a fibroblast pheno-
type, and begin remodeling and synthesizing new
ECM.15–17 While EMT plays an important part in the
regeneration of other tissues, the role of the EMT
process in tendon repair has not been previously
described.
To gain greater understanding of the fundamental
cellular and molecular biology of tendon repair, we
performed a tenotomy and repair in Achilles tendons
of adult rats and analyzed changes in macrophage
phenotype, and ECM- and EMT-related genes. Tissue
was harvested at 3, 7, 14, and 28 days after injury and
compared to uninjured controls. We hypothesized that
in response to a full-thickness tear of the Achilles
tendon there would be an early accumulation of M1
macrophages within the first week followed by gradual
transition to the M2 phenotype, and that tendon
repair would correlate with increased expression of
EMT-related genes.
METHODS
Animals and Surgical Procedure
The University of Michigan IACUC approved this study. Six-
month-old male Sprague–Dawley rats were randomized to
control, 3-, 7-, 14-, or 28-day groups (N¼ 6 rats per group).
Tendon surgery was performed on both Achilles tendons.
Rats were anesthetized with 2% isoflurane, and the skin
overlying the surgical site was shaved and scrubbed with 4%
chlorhexidine. A midline incision was created in the skin and
the paratenon was split to achieve visualization of the
Achilles tendon. A full-thickness tenotomy was performed in
the mid-substance of the tendon followed by immediate two-
strand repair using the Bunnell technique with 5-0 Ethibond
(Ethicon, Somerville, NJ) (Fig. 1). The plantaris tendon was
left intact. The paratenon was loosely re-approximated and
the skin closed using 4-0 Vicryl (Ethicon) and GLUture
(Abbott, Abbott Park, IL). A splash block of 0.5ml of 0.5%
bupivacaine, buprenorphine (0.05mg/kg), and carprofen
(5mg/kg) were administered for analgesia during post-opera-
tive recovery. Ad libitum weight-bearing and cage activity
were allowed. At harvest, rats were anesthetized with
pentobarbital (50mg/kg) and Achilles tendons were har-
vested for either gene expression analysis or immunohis-
tochemistry (IHC). Achilles tendons were also collected from
rats that did not undergo tenotomy and served as controls.
After the removal of tendons, animals were euthanized by
anesthetic overdose and induction of bilateral pneumothorax.
Gene Expression
The right Achilles tendon was homogenized in QIAzol
(Qiagen, Valencia, CA). RNA was isolated using a miRNeasy
Kit (Qiagen), treated with DNase I (Qiagen), and reverse
transcribed into cDNA using oligo-dT15 and random hexamer
primers with the RT2 Kit (Qiagen). cDNA was amplified in a
CFX96 real-time thermal cycler (Bio-Rad, Hercules, CA)
using a QuantiTect SYBR Green (Qiagen). The methods of
Livak and Schmittgen18 were used to normalize target gene
expression to the stable housekeeping gene b2-microglobulin
(B2M). Transcript information and the specific function of
each gene are provided in Supplementary Table S1.
Immunohistochemistry
Left Achilles tendons were isolated, snap frozen in TFM
(Triangle Biosciences, Durham, NC), and stored at 80˚C.
Tendons were sectioned through the callus at a thickness of
10mm in a cryostat. Slides were fixed in 4% paraformalde-
hyde, permeabilized in 0.2% Triton X-100, and blocked with
5% goat serum. Slides were incubated with primary anti-
bodies against rabbit anti-CCR7 (NB110-55680, Novus Bio-
logicals, Littleton, CO) and mouse anti-CD163 (MCA342B,
AbD Serotec, Raleigh, NC) to label M1 and M2 macrophages,
respectively.19,20 AlexaFluor 555 (AF555, Life Technologies,
Eugene, OR) secondary antibodies or streptavidin-AF647
were used to detect primary antibodies. DAPI was used to
identify nuclei and ECM was labeled with WGA-lectin
conjugated to AF488 (Life Technologies). Slides were
mounted and imaged using a Zeiss Axiovert 200M outfitted
with the ApoTome system (Carl Zeiss, Thornwood, NY).
Statistical Analyses
Results are presented as meanSE. Prism 6.0 software
(GraphPad Software, La Jolla, CA) was used to conduct
analyses. A one-way ANOVA (a¼ 0.05) followed by Tukey’s
post-hoc sorting was performed to determine significance
between groups.
RESULTS
Control tendons demonstrated the presence of M2 and
occasional M1 macrophages in the endotenon layers,
but no macrophages in the tendon fibers (Fig. 2A).
Figure 1. Illustration of tendon repair. A full-thickness tenot-
omy is performed in the mid-substance of the Achilles tendon
and the plantaris tendon is left intact. The defect is then
repaired immediately using a two-strand core suture (Bunnell
technique).
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Three days following surgical tear and repair, M1
macrophages accumulated in regions of newly formed
tendon tissue and remained present throughout the
study period (Fig. 2B–E). M2 macrophages slowly
accumulated at sites of organizing tendon ECM and
became the predominant macrophage phenotype by
28 days (Fig. 2E). In most cases, after injury macro-
phages were localized in areas of tissue resorption as
indicated by the lack of WGA staining. The change in
M1 and M2 signal present in IHC was accompanied by
quantitative changes in gene expression. For genes
that regulate macrophage and neutrophil function
(Fig. 3), the neutrophil marker Ly6c was elevated by
3 days, but returned to levels similar to controls by
28 days. The pan-macrophage marker F4/80 was also
elevated by 3 days. However, after an initial decline at
7 days, it remained elevated compared to controls
thereafter. CCL2, which plays an important role in
macrophage recruitment, was elevated by 3 days and
then steadily declined over the next few weeks.
Markers of M1 macrophages such as CD68, CCR7 and
CD11b were dramatically elevated following surgical
tear and repair. CD68 and CD11b declined between 3
and 7 days. CD168, a marker for M2 macrophages,
remained similar to controls until day 28 at which
time it became significantly elevated. Pro-inflammato-
ry interleukins IL1b and IL6 were up-regulated by
3 days, but IL6 demonstrated a gradual decline in
expression between each time point. Up-regulation of
the anti-inflammatory interleukin IL10 did not occur
until 28 days.
For fibroblast proliferation and cell cycle control
factors (Fig. 4), the type II transmembrane protein
tenomodulin (Tnmd) promotes tendon fibroblast prolif-
eration and was significantly down-regulated by
3 days. It was then elevated compared to controls by
7 days with peak expression at 14 days. Scleraxis
(Scx), a bHLH transcription factor involved in tendon
development, was elevated by 7 days with a slight
decline in expression at 28 days. Alpha-smooth muscle
actin (SMA) is an indicator of fibroblast contractility
and was elevated at 7 days, but quickly returned to
levels similar to controls by 14 days. No changes in the
pan-fibroblast marker FSP1 were noted at any time
point. Moreover, no differences in Mohawk (Mkx)
expression, a marker of tendon maturation, were
observed. HIF1a serves as a gauge of tissue hypoxia
and was elevated by 3 days with further increases in
expression at 7 and 14 days. Egr1 and Egr2, transcrip-
tional regulatory proteins that are induced by various
mitogenic cues, were elevated by 7 days. While Egr1
returned to levels similar to controls by 14 days, Egr2
remained elevated for the remainder of the study
period. The cellular differentiation marker Aatk
remained similar to controls until day 28 at which
time its expression was up-regulated.
For EMT-related genes (Fig. 5), the transcription
factors Snail1 (Snai1) and Slug were elevated by
3 days and then declined by either 14 or 28 days,
respectively. Goosecoid (Gsc), a homeobox protein that
induces EMT, was elevated at 7 and 14 days compared
to controls. Twist1, a bHLH transcription factor that
also induces EMT, was elevated by 7 days and
returned to baseline levels by 28 days. No differences
in expression of the angiogenic factor VEGF or the
transcription factor Foxc2, which is induced by EMT
events, were noted at any time point. The endothelial
cell marker CD31 was elevated at 7 days and the cell
adhesion molecule E-cadherin (Cdh1) was significantly
up-regulated at 28 days. Ddr2, an EMT-responsive
receptor tyrosine kinase, was down-regulated by
3 days, but returned to levels similar to controls by
7 days.
For ECM gene expression (Fig. 6), the small leu-
cine-rich proteoglycan (SLRP), biglycan (Bgn), and the
cartilage-specific proteoglycan aggrecan (Acan) were
significantly elevated by 3 and 7 days, respectively.
Both remained elevated with a slight decrease be-
tween 14 and 28 days. In contrast, the SLRPs decorin
(Dcn), and fibromodulin (Fmod) were down-regulated
by 3 days, and only fibromodulin returned to levels
similar to controls by 7 days. The intermediate fila-
Figure 2. Macrophages accumulate sequentially in tendon
following surgical tear and repair. M2 macrophages are found in
the endotenon of non-operated controls (A), but not in the tendon
fibers. There is a dramatic accumulation of M1 macrophages in
regions of ECM resorption that remained consistent in the 3-day
(B), 7-day (C), and 14-day (D) groups. M2 macrophages become
the predominant phenotype by 28 days (E). M1 macrophages
(CCR7), red (and indicated by red arrowheads); M2 macrophages
(CD163), yellow (and indicated by yellow arrowheads); ECM
(WGA-lectin), green; nuclei (DAPI), blue. Asterisks indicate areas
of tissue resorption. All panels are shown at the same level of
magnification as in panel A.
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ment vimentin (Vim) was briefly up-regulated at
7 days, while the large proteoglycan versican (Vcan)
was significantly expressed by 3 days and then
steadily declined. Collagen type I (Col1a1) and type III
(Col3a1) were both up-regulated by 3 days with peak
expression at 7 days. Members of the MMP family
displayed similar levels of expression with up-regula-
tion of MMP2, MMP3, MMP8, and MMP14 by 3 days,
and MMP9 by 7 days. MMP2, MMP8, and MMP14
were maximally expressed at 14 days and declined
thereafter, while MMP9 steadily increased over the
next few weeks. TIMP1 was elevated by 3 days and
then declined by 14 days, whereas TIMP2 was elevat-
ed by 7 days with peak expression at 14 days.
DISCUSSION
While tendon injuries are common and can significant-
ly detract from the quality of life, compared with other
musculoskeletal tissues little is known about the
biology of tendon repair. This was the first study, to
our knowledge, that identified changes in canonical
EMT-related genes over the course of tendon injury
and repair. Further, we report changes in different
populations of macrophages, and fibroblast prolifera-
tion and ECM synthesis genes that play important
structural and mechanical roles in tendon. There
appears to be overlapping activation of various gene
families within the first 4 weeks of tendon repair, and
EMT-related factors may contribute to the repair
process in injured tendon tissue.
In response to structural damage, chemotactic
cytokines that promote the delivery of different cell
populations to the repair site are released from tendon
ECM.3,12 Phagocytic neutrophils and M1 macrophages
are the first to arrive within 24h after injury, followed
by a reparative shift in function that correlates with
Figure 3. Changes in gene expression of macrophage and neutrophil markers in Achilles tendon following surgical tear and repair.
Target genes were normalized to B2M expression, and further normalized to the control group. Differences were tested using a one-
way ANOVA (a¼0.05) followed by Tukey’s post-hoc sorting. (a) Different from control, (b) different from 3D, (c) different from 7D, and
(d) different from 14D. N¼6 tendons per group.
Figure 4. Changes in gene expression of fibroblast proliferation and cell cycle control factors in Achilles tendon following surgical
tear and repair. Target genes were normalized to B2M expression, and further normalized to the control group. Differences were tested
using a one-way ANOVA (a¼ 0.05) followed by Tukey’s post-hoc sorting. (a) Different from control, (b) different from 3D, (c) different
from 7D, and (d) different from 14D. N¼ 6 tendons per group.
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increases in M2 macrophages.1,2,5 Using ED1 (CD68)
and ED2 (CD163) to identify pro- and anti-inflamma-
tory macrophages, respectively, Marsolais et al.6 found
that following the injection of collagenase into tendons,
there was a rapid accumulation of M1 macrophages
that returned to baseline levels 2 weeks after injury.
No significant change in M2 macrophages was
detected over the course of the study. In a study that
explored early mechanical loading after collagenase
injection into tendons, Godbout et al.21 reported an
increase in M1 macrophages that was similar to
Marsolais et al.,6 but also that exercise increased M2
macrophages 3 days after injury. The results of the
current study are consistent with previous work as
evidenced by up-regulation of M1 markers CD68,
CCR7, and CD11b as well as interleukins IL1b and
IL6 within 72h. These pro-inflammatory factors
remained consistently elevated at each time point,
while the M2 marker CD168 and interleukin IL10
were not induced until 28 days. Similar observations
in the early M1 response were found in injured
skeletal muscle using a model of reloading after
hindlimb suspension.22,23 Following resumption of
weight bearing, M1 macrophages precipitously accu-
mulate in the reloaded muscle within 48h, but expres-
sion was more transient with the M1 signal returning
to levels similar to controls within 1 week post-injury.
Although, M2 macrophages also appeared at much
earlier time points, the sequential transition between
the M1 and M2 phenotypes supports the dual func-
tionality of this cell type in the degradation and repair
of injured tendons.
Following connective tissue injury, there is a pro-
nounced early increase in the numbers of macrophages
Figure 5. Changes in gene expression of EMT-related genes in Achilles tendon following surgical tear and repair. Target genes were
normalized to B2M expression, and further normalized to the control group. Differences were tested using a one-way ANOVA (a¼0.05)
followed by Tukey’s post-hoc sorting. (a) Different from control, (b) different from 3D, (c) different from 7D, and (d) different from 14D.
N¼ 6 tendons per group.
Figure 6. Changes in gene expression of ECM components and MMPs in Achilles tendon following surgical tear and repair. Target
genes were normalized to B2M expression, and further normalized to the control group. Differences were tested using a one-way
ANOVA (a¼0.05) followed by Tukey’s post-hoc sorting. (a) Different from control, (b) different from 3D, (c) different from 7D, and (d)
different from 14D. N¼6 tendons per group.
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and fibroblasts.1 While tendon fibroblasts are thought
to come from either a circulating pool of bone marrow-
derived progenitor cells or from resident populations of
tendon stem/progenitor cells,24 a growing body of
evidence in other tissues suggests that resident cells
in the host epithelium become activated and undergo
an EMT transcriptional reprogramming to a mesen-
chymal fibroblast phenotype.15,16 As cells undergo
EMT, they experience a loss of epithelial-associated
junctional complexes, begin to express mesenchymal
cell markers and acquire tissue-invasive properties
that allow them to transmigrate their basement
membrane and move into different environments. The
epitenon is an epithelial structure subtended by a
basement membrane,14 and prior work in in vitro and
in vivo models of lacerated flexor tendons has demon-
strated that fibroblasts migrate from this outer layer
into the site of tendon injury,14,25–27 as well as in
response to treadmill training.13 In the present study,
we found that following acute Achilles tenotomy and
repair there was a significant up-regulation of canoni-
cal EMT-related genes including Snail1, Slug, Goose-
coid, and Twist1. These transcription factors repress
cell adhesion proteins and induce metalloproteinases
that degrade the ECM and promote tissue invasion.28
Accompanying these changes were increased expres-
sion of mesenchymal tendon fibroblast markers scler-
axis and tenomodulin, as well as ECM-remodeling
enzymes MMP2, MMP3, MMP8, MMP9, and MMP14,
and their endogenous inhibitors TIMP1 and TIMP2.
Consistent with these results, other models of Achilles
tendon injury have demonstrated massive increases in
the expression of tendon-specific markers.29,30 More-
over, Scott and colleagues31 found that scleraxis,
tenomodulin, and type I collagen were significantly
expressed in an injured mouse patellar tendon 4 weeks
after a central defect was surgically created. Scleraxis
and type I collagen expression eventually returned to
baseline levels, but tenomodulin remained elevated
even at 12 weeks post-injury. Induction of MMP
expression has also been shown to correlate with
collagen turnover and ECM remodeling during tendon
repair.3,32 Further, proteoglycans are important regu-
lators of collagen fibril assembly and variations in
their content can greatly alter tendon structure and
function.33 Following surgical tear and repair of the
Achilles tendon, we observed an up-regulation of type
I and III collagens, aggrecan, biglycan and versican,
and a down-regulation of decorin and fibromodulin.
The reduction in decorin expression is supported by
previous studies that demonstrated decreased rates of
collagen fibrillogenesis in vitro in the presence of
decorin.34,35 In addition to abnormal fibril structure
and impaired mechanical function, decorin-deficient
tendons display an increase in biglycan expression.36
This may compensate for the loss of decorin as
biglycan is expressed during early tendon develop-
ment, but its expression normally declines as the
tendon matures.37 Similar to the altered tendon phe-
notype described in decorin-null mice, a deficiency of
fibromodulin also produces tendons with thin, irregu-
lar collagen fibrils.38 Aggrecan is a proteoglycan, that
is expressed during later stages of chondrogenesis,
and is also expressed in regenerating tendons follow-
ing tenotomy.39 Increased expression of aggrecan is
correlated with the induction of heterotopic ossification
in injured tendons,39 and although, we did not directly
measure other markers of osteogenesis, the increase in
aggrecan at later time points suggests some heterotop-
ic ossification was also occurring in our model. Overall,
findings from this study in conjunction with previous
work suggest that the assembly of the collagen net-
work during tendon repair may be mediated by the
temporal-specific expression of proteoglycans.
This study provided important insights into changes
in macrophage phenotype and EMT-related genes
following acute Achilles tenotomy and repair, but
there are several limitations. We did not immobilize
the hindlimbs post-operatively, which is standard
practice in patients undergoing Achilles tendon
repairs. However, the plantaris tendon was left intact,
and as plantaris is substantially larger in rats than
humans, this likely provides stress shielding for the
injured Achilles tendon. Immediate mobilization at the
repair site may have impacted the amount of inflam-
mation present, but should not have altered the
sequence of inflammatory cell accumulation within the
injured tissue. We also focused only on the Achilles
tendon and observed differences may not be reflected
in trunk or other limb tendons. While there are 26
known MMP genes,3 we evaluated only a subset of
MMPs that were selected from the four general classes
of MMPs. Our animal model is most representative of
acute tendon transections, and may not recapitulate
longstanding degenerative changes in the tendon
ECM. Finally, in addition to driving trans-differentia-
tion and migration through the EMT program, Snail1,
Slug, Goosecoid, and Twist1 have other EMT-indepen-
dent functions including cell lineage specification, cell
cycle regulation, apoptosis, and both ECM synthesis
and remodeling.40–43 While these results are encourag-
ing, whether EMT is truly occurring in tendon, or
fibroblasts emerging from the epitenon are simply
proliferating populations of resident cells, remains to
be determined. Further studies are needed to decipher
the specific roles of these genes during tendon repair.
This study evaluated changes in the expression of
EMT-related genes during the repair of injured tendon
tissue, but changes in the levels of specific proteins
were not investigated. However, previous studies in
other tissues have demonstrated that changes in the
expression of specific EMT-related genes correlate
with changes in the abundance of the translated
proteins.44,45
Injuries to and diseases of tendons are a substantial
economic and health burden among patients of all
ages. Non-operative interventions focus on symptomat-
ic relief, and even with surgery patients may have
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poor outcomes and continue to experience pain and
reduced function.1 A more direct approach to the
management of tendon injuries is needed, and the
current lack of targeted therapies is due in part to our
limited mechanistic insight into basic physiological
processes that control tendon repair. Findings from
this study and from Marsolais et al.6 demonstrate that
macrophages change phenotype in response to tendon
damage and this likely contributes to the degradation
and subsequent repair of injured tendon ECM. Fur-
ther investigation of the specific functions of macro-
phage sub-populations in tendon is therefore
warranted. Lastly, given the critical role EMT plays in
the post-natal growth of many tissues in the body and
in pathologic conditions such as tissue fibrosis, the
expression of EMT-related genes during tendon repair
may prove to be a worthwhile area of scientific
exploration.
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